B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial targets tough blood cancers and anemia
Disease control Recruiting nowThis early-phase study is testing a new cell therapy called GT801 in adults with advanced blood cancers or autoimmune anemia that has not responded to standard treatments. The main goals are to check if the treatment is safe and to see early signs of whether it helps control the …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New leukemia treatment begins first human testing
Disease control Recruiting nowThis early study is testing a new treatment called JY231 injection for adults and children with B-cell acute lymphoblastic leukemia (B-ALL). Researchers will give the injection to 20 participants to check if it's safe and what side effects might occur. They'll also look for early…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: EARLY_PHASE1 • Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Faster Cancer-Fighting cells: new hope for kids with tough leukemia
Disease control Recruiting nowThis study is testing a new, faster way to make a personalized cancer treatment called CAR-T cell therapy for children and young adults with a hard-to-treat blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). The goal is to see if using an automated machine to make t…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis study is testing a new drug called AZD4512 for people with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or hasn't responded to other treatments. The main goals are to find a safe dose and see if the drug can help patients achieve remission. The study will e…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New drug trial offers hope for Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing an experimental drug called AZD0486 for adolescents and adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or hasn't responded to at least two prior treatments. The main goals are to find a safe and effective dose and to see if the dr…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Do cancer drugs wipe out Kids' vaccine shields? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand if a common leukemia treatment called blinatumomab weakens the protection from childhood vaccines. Researchers will check antibody levels in up to 300 young patients (under 21) who have been treated for B-cell leukemia. They want to see if these pati…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
First major study to track Long-Term health after revolutionary cancer treatment
Knowledge-focused Recruiting nowThis study aims to understand the long-term health of young people who survived B-cell acute lymphoblastic leukemia (B-ALL) after receiving CAR T-cell therapy. Researchers will follow 80 survivors who are at least two years past their treatment to check for any late-developing he…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC